Loading company…
USK is a Shenzhen-based biotechnology company that provides molecular diagnostic products and tumour testing services.
Established in 2015 and based in Shenzhen, China, USK develops molecular diagnostic products for tumours, cardiovascular disease, infectious disease, and nucleic acid extraction. It also offers tumour ultra-early screening and personalized drug testing services, and holds 28 invention and utility model patents. The company is a National High-Tech Enterprise. Shenzhen Capital Group led a pre-A round in September 2020, and Winzac Capital Management made a strategic investment in June 2024.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in